Ian Demsky

Demsky was a previous Health Lab contributor and member of the public relations team.

Genetic testing DNA chromosomes 3
Health Lab

BRCA1 and BRCA2 Gene Mutations: I Have a Mutation, What Are My Options?

A genetic counselor discusses decision-making for people who carry BRCA1 and BRCA2 mutations
graphic drawing of chromosome on black background
Health Lab

BRCA1 and BRCA2 Gene Mutations: I Know I Have Cancer, What Good is Testing?

A genetic counselor discusses how genetic testing can help guide treatment decisions and well as inform preventive measures.
microscope drawn in blue ink on notepad paper
Health Lab

Scientists Develop First Drug-Like Compounds to Inhibit Elusive Cancer-Linked Enzymes

Structural biology techniques helped researchers target the nuclear receptor-binding SET domain family, whose malfunction is associated with several types of cancer.
Single cell RNA sequencing dots
Health Lab

Single-Cell RNA Sequencing Sheds New Light on Cancer Cells’ Varied Response to Chemotherapy

Single-cell RNA sequencing study offers new insights that could help researchers make chemotherapy more effective in the future.
genetic testing DNA chromosomes in blue
Health Lab

BRCA1 and BRCA2 Gene Mutations: The Basics

A genetic counselor discusses the impact of these mutations and the importance of collecting family histories.
Daniel Wahl and researcher looking and pointing at slide
Health Lab

Study Suggests New Potential Approach Against Fatal Childhood Brain Cancer

In mouse models of DIPG, simultaneously attacking two metabolic pathways led to significant improvements in survival.
drawing of cancer cells
Health Lab

Prostate Cancer Treatment Might Help Some Glioblastoma Patients

Anti-androgen therapy showed positive results in cell lines and animal models.
2 doctors looking at slide in lab
Health Lab

Study Suggests New Approach to Improve Radiation Therapy Resistance in Glioblastoma

Cancer treatment research for glioblastoma enters new phase with FDA-approved drug trial that aims to improve the effect of radiation therapy on this aggressive brain cancer.
drawing of microscope on lined paper
Health Lab

Researchers Optimistic After Dose-Determining Trial of Compound Against Metastatic Castration-Resistant Prostate Cancer

The multi-institution phase 1b/2a clinical trial found good tolerability and encouraging efficacy data for the pan-BET bromodomain inhibitor in combination with enzalutamide.
drawing of microscope on paper
Health Lab

Inhibiting Key Molecular Chaperone Sensitizes Tumors to Radiation Therapy in Animal Models

While heat shock protein 90 inhibitors have shown limited benefit in directly treating cancer, low doses may improve the efficacy of radiotherapy, a new study finds.
drawing of DNA on paper
Health Lab

New Clues in Resistance to Mainstay Drug for Patients with Metastatic Prostate Cancer

Multi-institution analysis identifies a new chromosomal abnormality linked to enzalutamide resistance.
image of lung cancer scanning graphic image
Health Lab

Experts Say More People Should Get Lung Cancer Screenings, and Sooner

A Rogel Cancer Center lung doctor discusses recommendations that annual screenings start at age 50 for current and former smokers with 20 “pack years”.
Patient doctor talking
Health Lab

What is Advanced Cancer?

The terms can be confusing — advanced cancer, metastatic cancer, late-stage cancer, stage 4 cancer, secondary cancer, recurrent cancer. Here’s what patients need to know.
pancreatic cancer graphic
Health Lab

Study Suggests Method to Starve Pancreatic Cancer Cells

Rather than attacking cancer cells directly, new cell-model research probes weaknesses in pancreatic cancer’s interactions with other cells to obtain nutrients needed for tumor growth.
Ovarian Cancer Cells
Health Lab

This MicroRNA Might Help Detect, Treat Ovarian Cancer

New ovarian cancer research shows microRNA biomarker miR-181a could hold the key to earlier detection and treatment of the disease.
  • 3
  • 4
  • 5